Full-Time

Vaccines Medical Affairs Lead

Posted on 4/3/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Expert

Santa Fe, NM, USA

This role is open to candidates from Mexico, Colombia, Argentina, Chile, Brazil, Peru, Panama, and Guatemala. Requires travel 30% to 40% of the time.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Takeda referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • MD (preferred). PhD qualifications may be considered in the case of applicants who are established leaders in Vaccines.
  • Minimum of 10 years of medical affairs and/or clinical development experience in the pharmaceutical industry at regional and global level.
  • Strong vaccines expertise is key requirement. Proven track records of vaccines launch across different infectious diseases areas, across the life-course, and in different geographies in both private and public programs.
  • In depth knowledge of the PAHO countries healthcare system and vaccine implementation framework is considered an asset.
  • Knowledge of GAVI framework for vaccine implementation in low-income countries, UNICEF Vaccine strategy and projects, in particular in LATAM countries, is preferred.
  • In depth knowledge of industry, vaccines business and products, countries in scope and key stakeholders’ particularities.
  • Recognized internally and externally as a vaccine expert. Superior scientific, clinical, credibility, with strong track records of publications and speaking activities in the field.
  • In depth knowledge of the international public health healthcare environment, able to identify and contribute to healthcare trends and in maximizing related medical opportunities.
  • Fluent in Spanish and English required, knowledge of other languages such as Portuguese is a plus.
Responsibilities
  • Provide near and long-term strategic direction as well as development and oversight of the scientific platform in support of the vaccine product strategies for the region.
  • Shape the scientific understanding and narrative for vaccines across the LATAM region, particularly for TAK-003 dengue vaccine.
  • Provide vaccines medical leadership to LATAM Countries enhancing cross functional organizational excellence with Evidence Generation and Publications, Public Affairs, Market Access and other relevant cross-functional teams.
  • Lead LATAM regional medical initiatives to support licensure and introduction of vaccine products, including efforts to support recommendations in supranational and national vaccination schedules by supranational bodies.
  • Serve as key medical liaison with LATAM regional non-governmental and governmental organizations such as PAHO, GAVI, UNICEF etc., on scientific and policy issues for vaccines in general and in particular TAK-003 dengue vaccine.
  • Establish, develop, and drive strong relationships with key external medical and public health stakeholders, Professional Associations, key external institutions at LATAM level through scientific discussions and projects to build Takeda regional leadership in vaccine preventable diseases.
  • Interact internally with LATAM, GEM and Vaccines Business Unit (VBU) Leaders. Advise and negotiate, as required, to guide the overall vaccine medical activities.
  • Contribute to building, training, and supporting LOC Medical Affairs staff to introduce vaccines into respective national programs in LATAM.
  • Ensure that LATAM and LOC medical needs are considered when elaborating GEM and global Medical Affairs strategies.
  • Provide medical direction and review for pre- and post-launch medical and public health policies strategies in LATAM.
  • Ensure that medical activities in the LATAM Region and LOCs are compliant with all applicable local and regional regulations and obligations, as well as in line with Takeda’s own Ethical Guidelines and Business Practices.
Desired Qualifications
  • Knowledge of GAVI framework for vaccine implementation in low-income countries, UNICEF Vaccine strategy and projects, in particular in LATAM countries, is preferred.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that patient needs guide their operations. The company aims to launch up to 15 new products by FY2024 and has a strong pipeline of 11 NMEs. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

INACTIVE